Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cell Reports. Medicine|December 30, 2020
Modulation of Immune Checkpoints by Chemotherapy in Human Colorectal Liver MetastasesNeda Jabbari, Heidi L Kenerson, Christopher Lausted, et al.European Journal of Cancer (Oxford, England : 1990)|August 17, 2025
Enfortumab vedotin in patients with advanced non-small cell lung cancer after disease progression on platinum- and PD-1/PD-L1 inhibitor-containing regimens: Phase 2 international multicenter EV-202 studyKei Muro, Trevor Feinstein, Joaquina Baranda, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2026
Enfortumab vedotin plus pembrolizumab as first-line treatment in recurrent or metastatic head and neck squamous cell carcinoma: results from EV-202 cohort 9Paul L Swiecicki, Glenn J Hanna, Jessica L Geiger, et al.Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.The New England Journal of Medicine|February 18, 2026
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder CancerChristof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2022
Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled TrialMrinal M Gounder, Albiruni Abdul Razak, Neeta Somaiah, et al.Pageof 2